![Thomas E. Willnow](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas E. Willnow
Corporate Officer/Principal at Humboldt-Universität zu Berlin
Thomas E. Willnow active positions
Companies | Position | Start | End |
---|---|---|---|
Humboldt-Universität zu Berlin | Corporate Officer/Principal | 02/09/2009 | - |
Career history of Thomas E. Willnow
Former positions of Thomas E. Willnow
Companies | Position | Start | End |
---|---|---|---|
Recepticon ApS
![]() Recepticon ApS Pharmaceuticals: MajorHealth Technology ReceptIcon is a biotech company based on the identification of novel receptors in the kidney that are responsible for renal uptake and nephrotoxity of therapeutic drugs. The company is focused on the development of receptor antagonists that prevent accumulation of therapeutics in the kidney. Such antagonists can be used as active pharmaceutical ingredients for reformulation of marketed nephrotoxic drugs thereby precluding their toxic side effects. | Director/Board Member | 01/01/2001 | 23/03/2010 |
Chief Tech/Sci/R&D Officer | 01/01/2001 | 23/03/2010 | |
Founder | 02/09/2009 | 23/03/2010 | |
MOLMED S.P.A. | Corporate Officer/Principal | 01/01/1996 | - |
Roche Diagnostics GmbH
![]() Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Corporate Officer/Principal | - | - |
Training of Thomas E. Willnow
Ludwig-Maximilians-Universität München | Doctorate Degree |
Statistics
International
Germany | 4 |
Denmark | 2 |
Italy | 2 |
Operational
Corporate Officer/Principal | 3 |
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 3 |
---|---|
Recepticon ApS
![]() Recepticon ApS Pharmaceuticals: MajorHealth Technology ReceptIcon is a biotech company based on the identification of novel receptors in the kidney that are responsible for renal uptake and nephrotoxity of therapeutic drugs. The company is focused on the development of receptor antagonists that prevent accumulation of therapeutics in the kidney. Such antagonists can be used as active pharmaceutical ingredients for reformulation of marketed nephrotoxic drugs thereby precluding their toxic side effects. | Health Technology |
Roche Diagnostics GmbH
![]() Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Commercial Services |
AGC Biologics SpA
![]() AGC Biologics SpA Pharmaceuticals: MajorHealth Technology AGC Biologics SpA engages in the research, development, manufacturing, and clinical validation of cell and gene therapies for the treatment of cancer and rare diseases. Its approach is based on finding drugs that target the reduction of tumor mass in the acute stage, as well as on the provision of selective therapies to eliminate the residual disease. It also conducts cell and gene therapy projects in collaboration with third parties, offering resources and expertise covering preclinical to Phase III trial activities. The company was founded by Claudio Bordignon on July 11, 1996 and is headquartered in Milan, Italy. | Health Technology |
- Stock Market
- Insiders
- Thomas E. Willnow
- Experience